Bactiguard Valuation Multiples

Bactiguard Overview

About Bactiguard

Bactiguard Holding AB is a medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Founded

2005

HQ

Employees

177

Website

bactiguard.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $25M

EBITDA: $4M

EV

$79M

Valuation Multiples

Multiples.vc

Start free trial

Bactiguard Financials

Bactiguard reported last 12-month revenue of $25M and EBITDA of $4M.

In the same LTM period, Bactiguard generated $4M in EBITDA and had net loss of ($2M).

Bactiguard P&L

In the most recent fiscal year, Bactiguard reported revenue of $25M and EBITDA of $5M.

Bactiguard expects next 12-month revenue of XXX and NTM EBITDA of XXX

Bactiguard Stock Performance

Bactiguard has current market cap of $66M, and enterprise value of $79M.

Bactiguard's stock price is $1.89.

Bactiguard Valuation Multiples

Bactiguard trades at 3.2x EV/Revenue multiple, and 22.5x EV/EBITDA.

Bactiguard Financial Valuation Multiples

As of April 20, 2026, Bactiguard has market cap of $66M and EV of $79M.

Equity research analysts estimate Bactiguard's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Bactiguard has a P/E ratio of (34.2x).

Bactiguard Margins & Growth Rates

Bactiguard's revenue in the last 12 month grew by 5%.

Bactiguard's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Bactiguard's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bactiguard's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Bactiguard Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Bactiguard M&A Activity

Bactiguard acquired XXX companies to date.

Last acquisition by Bactiguard was on XXXXXXXX, XXXXX. Bactiguard acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Bactiguard Investment Activity

Bactiguard invested in XXX companies to date.

Bactiguard made its latest investment on XXXXXXXX, XXXXX. Bactiguard invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).